Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 775309
                    [Title] => Efforts on to finally eliminate leprosy
                    [Summary] => 
Novartis will continue its work with the World Health Organization (WHO) toward a world free of leprosy by extending its drug donation of multidrug therapy (MDT) medicine to treat leprosy through the year 2020.
                    [DatePublished] => 2012-02-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 738874
                    [Title] => Novartis employees join first global health, well-being initiative
                    [Summary] => 
Associates of the Novartis Group Co. across 32 countries recently participated in a new Novartis health and well-being initiative during the first Novartis Be Healthy Celebration Week.
                    [DatePublished] => 2011-10-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

JOSEPH JIMENEZ

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 775309
                    [Title] => Efforts on to finally eliminate leprosy
                    [Summary] => 
Novartis will continue its work with the World Health Organization (WHO) toward a world free of leprosy by extending its drug donation of multidrug therapy (MDT) medicine to treat leprosy through the year 2020.
                    [DatePublished] => 2012-02-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 738874
                    [Title] => Novartis employees join first global health, well-being initiative
                    [Summary] => 
Associates of the Novartis Group Co. across 32 countries recently participated in a new Novartis health and well-being initiative during the first Novartis Be Healthy Celebration Week.
                    [DatePublished] => 2011-10-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Efforts on to finally eliminate leprosy

February 9, 2012 - 12:00am

Novartis will continue its work with the World Health Organization (WHO) toward a world free of leprosy by extending its drug donation of multidrug therapy (MDT) medicine to treat leprosy through the year 2020.

Science and Environment

Novartis employees join first global health, well-being initiative

October 20, 2011 - 12:00am

Associates of the Novartis Group Co. across 32 countries recently participated in a new Novartis health and well-being initiative during the first Novartis Be Healthy Celebration Week.

Science and Environment